Luther King Capital Management (LKCM)’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-250
| Closed | -$7K | – | 526 |
|
|
2016
Q3 | $7K | Hold |
250
| – | – | ﹤0.01% | 489 |
|
|
2016
Q2 | $7K | Hold |
250
| – | – | ﹤0.01% | 512 |
|
|
2016
Q1 | $7K | Hold |
250
| – | – | ﹤0.01% | 506 |
|
|
2015
Q4 | $4K | Hold |
250
| – | – | ﹤0.01% | 517 |
|
|
2015
Q3 | $4K | Hold |
250
| – | – | ﹤0.01% | 529 |
|
|
2015
Q2 | $7K | Hold |
250
| – | – | ﹤0.01% | 544 |
|
|
2015
Q1 | $7K | Hold |
250
| – | – | ﹤0.01% | 537 |
|
|
2014
Q4 | $7K | Hold |
250
| – | – | ﹤0.01% | 551 |
|
|
2014
Q3 | $9K | Hold |
250
| – | – | ﹤0.01% | 555 |
|
|
2014
Q2 | $11K | Hold |
250
| – | – | ﹤0.01% | 546 |
|
|
2014
Q1 | $12K | Hold |
250
| – | – | ﹤0.01% | 535 |
|
|
2013
Q4 | $9K | Hold |
250
| – | – | ﹤0.01% | 512 |
|
|
2013
Q3 | $26K | Hold |
250
| – | – | ﹤0.01% | 669 |
|
|
2013
Q2 | $19K | Buy |
+250
| New | +$19K | ﹤0.01% | 672 |
|